Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:18:08 EDT Fri 17 Apr 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDNA - MEDICENNA THERAPEUTICS CORP. J - https://www.medicenna.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDNA - T  5.00.60·0.643.00.60    1.97  0.59Apr 16Apr 1415 min RT 2¢
TSX - T5.00.60·0.643.00.60    1.97  0.59Apr 1615 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-04-14 07:30C:MDNA0.615News ReleaseMedicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
2026-04-09 12:49C:MDNA0.65News ReleaseMedicenna appoints Ibrahim as chief medical officer
2026-03-18 07:30C:MDNA0.76News ReleaseMedicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026
2026-02-18 07:30C:MDNA0.82News ReleaseMedicenna Therapeutics Announces Participation in Upcoming Conferences
2026-02-13 15:24C:MDNA0.83News ReleaseMedicenna's Dec. 31 cash at $10.6-million
2026-02-13 12:25C:MDNA0.76News ReleaseMedicenna appoints Sutin, Georgakis as directors
2026-02-12 21:04C:MDNA0.76SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-02-12 21:04C:MDNA0.76SEDAR Interim MD & ASEDAR Interim MD & A
2026-01-15 17:45C:MDNA0.93News ReleaseMedicenna sets out plans, milestones for 2026
2025-12-10 07:30C:MDNA1.61News ReleaseMedicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors
2025-12-09 17:04C:MDNA1.61News ReleaseMedicenna Therapeutics to Host a Live Webinar with Q&A to Discuss Updated MDNA11 Clinical Data
2025-11-13 17:43C:MDNA1.37News ReleaseMedicenna's fiscal Q2 2026 R&D expenses at $4.1M
2025-11-12 19:36C:MDNA1.38SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-12 19:36C:MDNA1.38SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-06 12:56C:MDNA1.53News ReleaseMedicenna joins Fondazione Melanoma for MDNA11 trial
2025-10-23 17:12C:MDNA1.06News ReleaseUpdated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
2025-10-20 07:00C:MDNA0.90News ReleaseMedicenna Therapeutics Announces Participation in Upcoming Conferences
2025-10-01 09:35C:MDNA0.98News ReleaseROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
2025-10-01 07:00C:MDNA0.98News ReleaseMedicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
2025-09-25 21:19C:MDNA0.94News ReleaseMedicenna shareholders approve AGM resolutions